Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kaye

Showing results (321-330 of 740) with videos related to

Pageof 74
Sort By:
Eye (London, England)|September 17, 2021
Patient-reported outcome measures for a large cohort of serum eye drops recipients in the UKR J Lomas, A Chandrasekar, C Macdonald-Wallis, et al.
American Journal of Infection Control|March 4, 2014
Effectiveness and cost of implementing an active surveillance screening policy for Acinetobacter baumannii: a Monte Carlo simulation modelJoseph R Coyle, Keith S Kaye, Thomas Taylor, et al.
Gene Expression|June 18, 2004
A high proportion of chromosome 21 promoter polymorphisms influence transcriptional activityPaul R Buckland, Sharol L Coleman, Bastiaan Hoogendoorn, et al.
British Journal of Cancer|November 25, 2005
Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trialC Rothermundt, R Hubner, T Ahmad, et al.
Pharmacogenetics|May 7, 2004
Promoter polymorphisms in glutathione-S-transferase genes affect transcriptionCarol A Guy, Bastiaan Hoogendoorn, S Kaye Smith, et al.
American Journal of Infection Control|April 4, 2015
Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction ProgramTeena Chopra, Anupama Neelakanta, Carolyn Dombecki, et al.
Journal of Virological Methods|August 29, 2000
Comparison of a point mutation assay with a line probe assay for the detection of the major mutations in the HIV-1 reverse transcriptase gene associated with reduced susceptibility to nucleoside analoguesJ R Clarke, S Kaye, A G Babiker, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing EnterobacteriaceaeMitchell J Schwaber, Shiri Navon-Venezia, Keith S Kaye, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladderG Blackledge, J T Roberts, S Kaye, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Challenges and Opportunities in Antimicrobial Stewardship among Hematopoietic Stem Cell Transplant and Oncology PatientsAnjali Majumdar, Mansi R Shah, Jiyeon J Park, et al.
Pageof 74

Showing results (321-330 of 740) with videos related to

Sort By:
Pageof 74
Eye (London, England)|September 17, 2021
Patient-reported outcome measures for a large cohort of serum eye drops recipients in the UKR J Lomas, A Chandrasekar, C Macdonald-Wallis, et al.
American Journal of Infection Control|March 4, 2014
Effectiveness and cost of implementing an active surveillance screening policy for Acinetobacter baumannii: a Monte Carlo simulation modelJoseph R Coyle, Keith S Kaye, Thomas Taylor, et al.
Gene Expression|June 18, 2004
A high proportion of chromosome 21 promoter polymorphisms influence transcriptional activityPaul R Buckland, Sharol L Coleman, Bastiaan Hoogendoorn, et al.
British Journal of Cancer|November 25, 2005
Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trialC Rothermundt, R Hubner, T Ahmad, et al.
Pharmacogenetics|May 7, 2004
Promoter polymorphisms in glutathione-S-transferase genes affect transcriptionCarol A Guy, Bastiaan Hoogendoorn, S Kaye Smith, et al.
American Journal of Infection Control|April 4, 2015
Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction ProgramTeena Chopra, Anupama Neelakanta, Carolyn Dombecki, et al.
Journal of Virological Methods|August 29, 2000
Comparison of a point mutation assay with a line probe assay for the detection of the major mutations in the HIV-1 reverse transcriptase gene associated with reduced susceptibility to nucleoside analoguesJ R Clarke, S Kaye, A G Babiker, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2006
Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing EnterobacteriaceaeMitchell J Schwaber, Shiri Navon-Venezia, Keith S Kaye, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladderG Blackledge, J T Roberts, S Kaye, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Challenges and Opportunities in Antimicrobial Stewardship among Hematopoietic Stem Cell Transplant and Oncology PatientsAnjali Majumdar, Mansi R Shah, Jiyeon J Park, et al.
Pageof 74